SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-102132
Filing Date
2023-09-20
Accepted
2023-09-20 08:00:15
Documents
12
Period of Report
2023-09-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326466d1_8k.htm   iXBRL 8-K 36388
  Complete submission text file 0001104659-23-102132.txt   210607

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA armp-20230914.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20230914_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20230914_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2326466d1_8k_htm.xml XML 3199
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 231265317
SIC: 2836 Biological Products, (No Diagnostic Substances)